Split dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL

Affiliations

• ¹ Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA. zaid.alkadhimi@unmc.edu.
• ² Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
• ³ Division of Hematology/Oncology, Aurora Health Care, Milwaukee, WI, USA.
• ⁴ Division of Hematology & Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
• ⁵ Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, NY, USA.
• ⁶ Division of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.